The global beauty industry generated $439 billion in 2025 and is in the middle of an M&A supercycle that is quietly restructuring who owns, who sells, and who revives the brands that define a $600 billion sector. In 2025 alone, 56 transactions were announced at multiples of 14.9× EV/EBITDA — five times the consumer industry average. L’Oréal spent €4 billion on Kering Beauty. Kimberly-Clark bid $48.7 billion for Kenvue. e.l.f. paid $1 billion for Hailey Bieber’s Rhode. And in the quietest deal of all, a French entrepreneur named Matthieu Lesieur — whose father had owned Decléor in the 1980s before selling it to Shiseido — bought the brand back from L’Oréal after they discontinued it, relaunched it on QVC in March 2026, and bet that aromatherapy skincare would bloom a second time. The big players are pruning. The small players are planting. Clean beauty is growing at 16.8% CAGR. And the most significant US cosmetics regulation since 1938 is entering enforcement. The second bloom is not cosmetic. It is structural.
Analysis via 🪺 6D Foraging Methodology™
Something structural is happening in beauty. The conglomerates that spent the 2010s acquiring every promising indie brand are now divesting the ones that did not fit. L’Oréal discontinued Decléor in 2023 and sold Carol’s Daughter after a decade of ownership. LVMH is reportedly exploring a sale of its 50% share of Fenty Beauty. Estée Lauder’s new CEO is assessing the entire portfolio, with California-based brands most likely to be divested. Unilever spun off Kate Somerville. Windsong Global acquired KVD Beauty. The pattern is consistent: portfolio optimisation by the majors is creating a supply of heritage brands at the exact moment a new class of buyer is emerging to acquire them.[1][2]
The new buyers are not private equity firms running playbooks. They are founder-operators with personal connections to the brands they are acquiring. Matthieu Lesieur, whose father Hervé owned Decléor before selling it to Shiseido in 2000, founded Cospal specifically to buy the brand back from L’Oréal and relaunch it. Charles Denton, former CEO of The Body Shop and Molton Brown, acquired Bodycare out of administration with plans to relaunch 30–50 stores in 2026. Goodai, a new entity backed by The Hahm Partners, is positioning itself to revitalise heritage beauty brands with global recognition. These are not financial engineers. They are people who know the brands, know the customers, and believe the heritage has commercial value that the conglomerates failed to unlock.[3][4]
The financial backdrop is extraordinary. Beauty M&A multiples averaged 14.9× EV/EBITDA in 2025 — more than five times the consumer industry average. Strategic buyers accounted for 43 of 56 deals, up 22.9% year over year. K-beauty M&A hit a post-pandemic record: 26 deals worth approximately $1.8 billion. And the anchoring transaction — Kimberly-Clark’s $48.7 billion bid for Kenvue, owner of Neutrogena, Aveeno, and OGX — is expected to close in the second half of 2026, creating a major global health and wellness company. Capstone Partners and DC Advisory both forecast acceleration in 2026. The sector, as Bloomberg recently put it, is the inescapable business of beauty.[5][6]
“Dealmaking appetite has remained strong among private strategics, while public companies have increasingly returned to the M&A market as trade volatility and market uncertainty have tempered.”
— Capstone Partners, Beauty M&A Update, December 2025[5]Underneath the deal flow is a consumer trend that is no longer a trend. Clean beauty — products formulated without harmful or toxic chemicals, with transparent ingredient labelling — was valued at roughly $10.5 billion in 2025 and is growing at 16.8% CAGR. Research shows 68% of consumers now actively seek out skincare products made with clean ingredients; 74% consider organic ingredients important. The premium tier is growing at 11.74% CAGR even at higher price points, indicating that consumers are willing to pay more when efficacy and ethical sourcing align. Asia-Pacific leads growth at 12%+ CAGR, but North America remains the largest national market. This is the demand signal the heritage revivals are riding.[7][8]
The Modernization of Cosmetics Regulation Act — the first major update to US cosmetics regulation since 1938 — is signed by President Biden on December 29, 2022. Mandatory facility registration, adverse event reporting, and ingredient disclosure become law.
December 29, 2022L’Oréal’s dermatological beauty division stops commercialising Decléor to focus on its core dermocosmetics brands. The aromatherapy pioneer founded in 1974 goes dark after nearly 50 years.
October 2023e.l.f. Beauty acquires Rhode (Hailey Bieber) for $1 billion. L’Oréal acquires Medik8 for approximately €1 billion. Unilever acquires Dr. Squatch for $1.5 billion. 16 US beauty transactions announced by mid-year.
January–June 2025L’Oréal acquires Kering Beauty for €4 billion. Kimberly-Clark announces $48.7 billion bid for Kenvue. Sycamore completes $10 billion WBA acquisition, creating The Boots Group. K-beauty hits 26 deals / $1.8 billion. L’Oréal doubles its Galderma stake to 20%. Cospal acquires Decléor and Saint-Gervais Mont Blanc from L’Oréal.
July–December 2025Decléor relaunches on QVC. Estée Lauder announces acquisition of remaining stake in Forest Essentials (Ayurvedic cosmetics). FDA updates Cosmetics Direct portal with real-time compliance tracking. Fragrance allergen labelling rule targeted for May 2026. Talc/asbestos testing final rule targeted for March 2026. Pat McGrath Labs assets marketed for sale. Parfums de Marly parent Advent International in early sale talks at >$2 billion valuation.
January–March 2026The cascade originates in D1 (Customer). Consumer demand for clean, transparent, wellness-adjacent beauty is the engine driving the entire sector reconfiguration. 68% of consumers actively seek clean ingredients. Gen Z and Millennials are the primary growth demographic, discovering brands through social commerce and demanding ingredient transparency that aligns with the MoCRA regulatory framework arriving simultaneously from D4.
D1 cascades into D3 (Revenue) through the M&A supercycle — 56 deals at 14.9× multiples, clean beauty at 16.8% CAGR, and the $48.7 billion Kenvue anchor. It cascades into D5 (Quality) through rising demands for clinical efficacy, dermatologist-backed formulations, and biotech acquisitions like Olaplex’s purchase of a biotech firm. And it cascades into D2 (Employee) through the emergence of a new acquirer category: founder-operators and brand builders (Cospal, Goodai, Rare Beauty Brands) who are reshaping the talent and organisational structure of the industry.
At L2, D3 (Revenue) cascades into D6 (Operational) as distribution models are overhauled — Decléor going QVC-first, TikTok Shop and Amazon gaining prominence, Instagram beauty earned media value dropping 28%. And D3 cascades into D4 (Regulatory) as the financial scale of the sector attracts regulatory scrutiny: MoCRA enforcement, EU Green Claims Directive, and fragrance allergen labelling all converging in 2026.
-- The Second Bloom: 6D Amplifying Cascade
FORAGE second_bloom
WHERE beauty_market_size >= 439e9
AND ma_deal_count_2025 >= 56
AND ma_ev_ebitda_multiple >= 14.0
AND clean_beauty_cagr >= 0.15
AND consumer_clean_preference >= 0.68
AND heritage_brand_divestiture_count >= 5
AND founder_operator_acquisition = true
AND regulatory_regime_change = true
ACROSS D1, D2, D3, D4, D5, D6
DEPTH 3
SURFACE second_bloom
DRIFT second_bloom
METHODOLOGY 85 -- The thesis is well-documented: Capstone, DC Advisory, WWD, Kline, McKinsey all project beauty M&A acceleration. Clean beauty growth is confirmed across multiple research firms. MoCRA timeline is published. Heritage brand revival pattern is observable across 5+ brands. Conglomerate portfolio optimisation is stated corporate strategy.
PERFORMANCE 35 -- Execution proof is early. Decleor just relaunched in March 2026 with no sales data yet. Cospal is newly formed with zero track record. Bodycare store reopenings are planned but not yet operational. Kenvue deal awaits regulatory approval. Heritage brands that were shelved may not return to scale. The thesis is sound. The performance data is 6-12 months away.
FETCH second_bloom
THRESHOLD 1000
ON EXECUTE CHIRP amplifying "The $439B global beauty sector is in an M&A supercycle (56 deals, 14.9x multiples, $48.7B anchor). Conglomerates pruning portfolios. Heritage brands (Decleor, Bodycare, Carol's Daughter) acquired by founder-operators. Clean beauty at 16.8% CAGR. MoCRA entering enforcement (first US cosmetics regulation update since 1938). D1 origin: 68% consumer clean preference cascading through D3 (revenue/M&A), D5 (quality/efficacy), D2 (structural shift to brand builders), then D6 (distribution revolution) and D4 (regulatory convergence). Chirp 60, DRIFT 50, Confidence 0.82. Teaching gap: well-documented thesis, early execution proof."
SURFACE analysis AS jsonRuntime: @stratiqx/cal-runtime · Spec: cal.cormorantforaging.dev · DOI: 10.5281/zenodo.18905193
Decléor is the micro-case inside the macro-story. Founded in 1974 as an aromatherapy skincare pioneer, the brand was acquired by Hervé Lesieur in 1989, sold to Shiseido in 2000, sold again to L’Oréal in 2014 as part of a €230 million package deal, moved between divisions, and finally discontinued in October 2023 when L’Oréal decided to focus on its core dermocosmetics offerings.[3]
Then Hervé’s son Matthieu approached L’Oréal. He founded Cospal in 2024, acquired both Decléor and Saint-Gervais Mont Blanc for an undisclosed amount, and announced plans to reinvent the brand from scratch — new product range, new distribution, new positioning. Before beauty, Lesieur had co-founded WeFix, a smartphone repair chain operating over 120 stores in France, which was later sold to the Fnac-Darty group. He is not a cosmetics industry veteran. He is a founder-operator who builds and scales consumer businesses, and whose family has deep knowledge of the specific brand he is reviving.[9][10]
The relaunch on QVC in March 2026 is itself a signal. Rather than rebuilding traditional retail distribution — an expensive, slow process for a brand with no current shelf presence — Cospal chose a direct-to-consumer channel that provides immediate access to an audience that skews toward the wellness and aromatherapy demographic. This mirrors the broader D6 (Operational) cascade: distribution models are being overhauled across the sector as Instagram beauty earned media value dropped 28% in Q1 2025 while TikTok Shop and Amazon gain prominence as discovery and purchase channels.[11]
Decléor is one data point. But it is the most structurally revealing data point because it combines every thread of the sector analysis into a single narrative: conglomerate divestiture, founder-operator acquisition, heritage brand revival, aromatherapy/wellness positioning, clean beauty consumer demand, and distribution innovation. If Decléor succeeds, it validates the entire thesis. If it fails, it illuminates where the teaching gap between methodology and performance becomes a structural barrier.
MoCRA — the Modernization of Cosmetics Regulation Act of 2022 — is the first significant update to US cosmetics regulation in 84 years. Before MoCRA, facility registration was voluntary, adverse event reporting was optional, and ingredient disclosure was largely unregulated. The cosmetics industry was the most loosely regulated consumer product category in the United States.[12]
MoCRA changed this fundamentally. Facility registration is now mandatory. Serious adverse events must be reported to the FDA within 15 days. Products from unregistered or improperly listed facilities are legally considered misbranded or adulterated, meaning border holds and import seizures are possible. In February 2026, the FDA updated its Cosmetics Direct portal with real-time registration status tracking — a signal that enforcement infrastructure is being built, not just rules.[13]
The regulatory timeline for 2026 is significant: a proposed rule on fragrance allergen labelling is targeted for May 2026, and a final rule on standardised asbestos testing in talc-containing cosmetics is targeted for March 2026. Good Manufacturing Practice regulations have been delayed to a long-term action list, partly due to the Trump administration’s one-in-ten-out regulatory approach, but the direction is clear. The EU Green Claims Directive, requiring scientific proof for environmental claims, also takes effect in 2026.[14][15]
For the heritage brand revival thesis, MoCRA is a structural tailwind. Brands with established safety infrastructure, documented formulations, and compliant manufacturing facilities have a competitive moat that new entrants must build from scratch. Decléor’s five decades of product history and L’Oréal-grade manufacturing heritage are, paradoxically, more valuable under MoCRA than they were before — even though L’Oréal chose to divest rather than maintain them. The acquirer benefits from the compliance investment the divester made.
Conglomerate portfolio optimisation is not destroying value — it is relocating it. When L’Oréal discontinues Decléor, the brand’s heritage, formulation IP, regulatory compliance history, and customer loyalty do not disappear. They become available at a discount to a buyer with lower overhead and higher conviction. The M&A supercycle is not just about big companies buying bigger. It is about big companies shedding what no longer fits, creating a supply of heritage assets that founder-operators can revive at fundamentally different cost structures.
Beauty M&A multiples at 14.9× EV/EBITDA — five times the consumer industry average — look like a premium until you examine the underlying growth. Clean beauty is growing at 16.8% CAGR. Premium beauty at 6.1% CAGR. The sector grew 11% year-over-year in the US to $108 billion. At these growth rates, a 14.9× multiple implies that buyers expect beauty to outperform consumer for the foreseeable future. The multiple is not speculative. It is discounting structural resilience.
MoCRA turns compliance from a cost into an asset. Mandatory facility registration, adverse event reporting, ingredient disclosure, and upcoming GMP standards all favour brands with existing safety infrastructure. Heritage brands that were manufactured under L’Oréal or Shiseido protocols carry compliance histories that new indie brands must build from scratch. The regulatory cascade (D4) does not just govern the market — it restructures competitive advantage toward exactly the kinds of brands being revived.
DRIFT of 50 (Methodology 85, Performance 35) is the honest reading. The thesis is well-documented, multi-sourced, and structurally sound. But the performance data does not yet exist. Decléor has no post-relaunch revenue. Cospal has no operating history. Bodycare stores have not reopened. The Kenvue deal has not closed. Every data point in this case describes either historical deals or forward-looking projections. The second bloom is planted. Whether it grows is a question for September 2026.
The 6D Foraging Methodology™ reads what others call “sector trends” and finds the cascade chain underneath. One conversation. We’ll tell you if the six-dimensional view adds something new.